TY - JOUR
T1 - Prevalence of Suicidality and its Association with Quality of Life in Older Patients with Clinically Stable Psychiatric Disorders in China During the COVID-19 Pandemic
AU - Liu, Rui
AU - Xu, Xiuying
AU - Zou, Siyun
AU - Li, Yulong
AU - Wang, Huan
AU - Yan, Xiaona
AU - Du, Xiangdong
AU - Zhang, Lan
AU - Zhang, Qinge
AU - Li, Wen
AU - Cheung, Teris
AU - Ungvari, Gabor S.
AU - Ng, Chee H.
AU - Xiang, Yu Tao
N1 - Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was supported by the National Science and Technology Major Project for investigational new drug (2018ZX09201-014), the Beijing Municipal Science & Technology Commission (No. Z181100001518005), the University of Macau (MYRG2019-00066-FHS), and the Suzhou Key Medical Center for Psychiatric Diseases (Szzx201509).
Publisher Copyright:
© The Author(s) 2022.
PY - 2022/3
Y1 - 2022/3
N2 - Aims: The pattern of suicidality in older patients with psychiatric disorders during the COVID-19 pandemic is not clear. This study examined the prevalence of suicidality and its association with quality of life (QOL) among older clinically stable patients with psychiatric disorders during the COVID-19 pandemic. Methods: A multicenter, cross-sectional study was conducted from May 22 to July 15, 2020, among four major tertiary psychiatric hospitals in China. Suicidality was assessed by asking 3 standardized questions. Depressive symptoms, pain, and QOL were assessed with the 9-item Patient Health Questionnaire (PHQ-9), the numeric pain rating scale (NPRS), and the World Health Organization Quality of Life Questionnaire-brief version, respectively. Results: A total of 1063 clinically stable patients participated and completed the assessment. The prevalence of suicidality was 11.8% (95% CI: 9.9%–13.7%) during the COVID-19 pandemic. Multiple logistic regression analysis revealed that poor treatment adherence (P =.009, OR = 1.86, 95% CI: 1.17–2.96) and perceived illness worsening during the COVID-19 outbreak (P =.02, OR = 2.07, 95% CI: 1.15–3.73), being diagnosed with major depressive disorder (P <.001, OR = 2.79, 95% CI: 1.68–4.64), PHQ-9 total score (P <.001, OR = 1.20, 95% CI: 1.15–1.24) and NPRS total score (P =.002, OR = 1.17, 95% CI: 1.06–1.29) were associated with higher risk of suicidality. After controlling for covariates, older psychiatric patients with suicidality had lower QOL compared to those without (F(1, 1063) =16.5, P<.001). Conclusions: Suicidality was common in older patients with clinically stable psychiatric disorders during the COVID-19 pandemic. Considering its negative impact on QOL and personal suffering, routine screening and preventive suicide measures should be implemented for older psychiatric patients.
AB - Aims: The pattern of suicidality in older patients with psychiatric disorders during the COVID-19 pandemic is not clear. This study examined the prevalence of suicidality and its association with quality of life (QOL) among older clinically stable patients with psychiatric disorders during the COVID-19 pandemic. Methods: A multicenter, cross-sectional study was conducted from May 22 to July 15, 2020, among four major tertiary psychiatric hospitals in China. Suicidality was assessed by asking 3 standardized questions. Depressive symptoms, pain, and QOL were assessed with the 9-item Patient Health Questionnaire (PHQ-9), the numeric pain rating scale (NPRS), and the World Health Organization Quality of Life Questionnaire-brief version, respectively. Results: A total of 1063 clinically stable patients participated and completed the assessment. The prevalence of suicidality was 11.8% (95% CI: 9.9%–13.7%) during the COVID-19 pandemic. Multiple logistic regression analysis revealed that poor treatment adherence (P =.009, OR = 1.86, 95% CI: 1.17–2.96) and perceived illness worsening during the COVID-19 outbreak (P =.02, OR = 2.07, 95% CI: 1.15–3.73), being diagnosed with major depressive disorder (P <.001, OR = 2.79, 95% CI: 1.68–4.64), PHQ-9 total score (P <.001, OR = 1.20, 95% CI: 1.15–1.24) and NPRS total score (P =.002, OR = 1.17, 95% CI: 1.06–1.29) were associated with higher risk of suicidality. After controlling for covariates, older psychiatric patients with suicidality had lower QOL compared to those without (F(1, 1063) =16.5, P<.001). Conclusions: Suicidality was common in older patients with clinically stable psychiatric disorders during the COVID-19 pandemic. Considering its negative impact on QOL and personal suffering, routine screening and preventive suicide measures should be implemented for older psychiatric patients.
KW - COVID-19
KW - older patients
KW - psychiatric disorder
KW - quality of life
KW - suicidality
UR - http://www.scopus.com/inward/record.url?scp=85125835156&partnerID=8YFLogxK
U2 - 10.1177/08919887221078557
DO - 10.1177/08919887221078557
M3 - Journal article
C2 - 35246000
AN - SCOPUS:85125835156
SN - 0891-9887
VL - 35
SP - 237
EP - 244
JO - Journal of Geriatric Psychiatry and Neurology
JF - Journal of Geriatric Psychiatry and Neurology
IS - 2
ER -